In 2026, the Hereditary Angioedema Working Group and the International Steering Committee issued the international guideline on the diagnosis and management of pediatric patients with hereditary angioedema (HAE). These guidelines elaborate on the definition, clinical features, diagnosis, and treatment of the disease, providing a decision-making basis for the clinical practice of pediatric HAE. This article interprets the main content of the guidelines.
